Neonatal lupus and IUGR following alpha-interferon therapy during pregnancy

Journal of Perinatology

Volumn 25, Issue 8, 2005, Pages 552-554

  Fritz, Melinda ^a   Vats, Kalyani ^b   Goyal, Rakesh K ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CYTOKINE; GENTAMICIN; HYDROCORTISONE; IRON; MULTIVITAMIN; PENICILLIN G; RECOMBINANT ALPHA2A INTERFERON;

ADOLESCENT; ARTICLE; CASE REPORT; CESAREAN SECTION; CHOREA; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; FACE DISORDER; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERBILIRUBINEMIA; INFANT; INTRAUTERINE GROWTH RETARDATION; LUPUS VULGARIS; NEUTROPENIA; NEWBORN DISEASE; POSTNATAL GROWTH; PREGNANCY; RASH; RHEUMATIC DISEASE; SEPSIS; SERODIAGNOSIS; SMALL FOR DATE INFANT; THROMBOCYTHEMIA;

ADOLESCENT; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, CUTANEOUS; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 23744436795     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211342     Document Type: Article

References (14)

1. Hiratsuka M, Minakami H, Koshizuka S, et al. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med 2000;28(5):372-6.
2. Griesshammer M, Heimpel H, Pearson TC. Essential thrombocythemia and pregnancy. Leuk Lymphoma 1996;22(Suppl 1):57-63.
3. Wright CA, Tefferi A. A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol 2001;66(3):152-9.
4. Harrison CN. Current trends in essential thrombocythaemia. Br J Haematol 2002;117(4):796-808.
5. Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood 2000;96(10):3343-56.
6. Chow EY, Haley LP, Vickars LM. Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome. Am J Hematol 1992; 41(4):249-51.
7. White PH. Pediatric systemic lupus erythematosus and neonatal lupus. Rheum Dis Clin North Am 1994;20(1):119-27.
8. Cincotta R, Higgins JR, Tippett C, et al. Management of essential thrombocythaemia during pregnancy. Aust N Z J Obstet Gynaecol 2000;40(1):33-7.
9. Pons JC, Lebon P, Frydman R, et al. Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage. Fetal Diagn Ther 1995;10(1):7-10.
10. Haggstrom J, Adriansson M, Hybbinette T, et al. Two cases of CML treated with alpha-interferon during second and third trimester of pregnancy with analysis of the drug in the new-born immediately postpartum. Eur J Haematol 1996;57(1):101-2.
11. Schmidt KN, Ouyang W. Targeting interferon-alpha: a promising approach for systemic lupus erythematosus therapy. Lupus 2004;13(5): 348-52.
12. Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 1994;20(1):87-118.
13. Yukiko N. Immune responses to SS-A 52-kDa and 60-kDa proteins and to SS-B 50-kDa protein in mothers of infants with neonatal lupus erythematosus. Br J Dermatol 2000;142(5):908-12.
14. von Marschall Z, Scholz A, Cramer T, et al. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst 2003;95(6):437-48.